Critical Role of Lipopolysaccharide-Binding Protein and CD14 in Immune Responses against Gram-Negative Bacteria
作者： Didier Le Roy , Franco Di Padova , Yoshiyuki Adachi , Michel Pierre Glauser , Thierry Calandra
DOI: 10.4049/JIMMUNOL.167.5.2759
关键词:
摘要: … LPS-binding protein (LBP) and CD14 potentiate cell … likely allows binding of LBP or CD14 to Gram-negative bacteria. … -negative bacteria, but did not bind to most live bacteria, including …
core.ac.uk
aai.org
jimmunol.org 
researchgate.net 参考文章(35)
A. Ishizaka, Hui Zheng, J. R. Hatherill, M. Yonemaru, R. S. Hogue, T. A. Raffin, J. J. Crowley, K. E. Stephens, Effects of tumor necrosis factor on PMN chemotaxis, chemiluminescence, and elastase activity. Journal of Laboratory and Clinical Medicine. ,vol. 114, pp. 674- 681 ,(1989)
R J Ulevitch, P Gallay, P S Tobias, C Barras, M P Glauser, D Heumann, J D Baumgartner, P Zaech, Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes. Journal of Immunology. ,vol. 148, pp. 3505- 3512 ,(1992)
T Calandra, D Heumann, M P Glauser, R Landmann, D Le Roy, S Lengacher, R Tees, F Di Padova, Monoclonal antibodies to murine lipopolysaccharide (LPS)-binding protein (LBP) protect mice from lethal endotoxemia by blocking either the binding of LPS to LBP or the presentation of LPS/LBP complexes to CD14. Journal of Immunology. ,vol. 162, pp. 7454- 7460 ,(1999)
M. P. Glauser, G. Zanetti, D. Heumann, C. Barras, J. Kohler, P. Abbet, Rudolf Lucas, J. D. Baumgartner, J. Gerain, Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy of antibodies to tumor necrosis factor-alpha and to lipopolysaccharide. Journal of Immunology. ,vol. 148, pp. 1890- 1897 ,(1992)
Robert S. Jack, Xiaolong Fan, Martin Bernheiden, Gabriele Rune, Monika Ehlers, Albert Weber, Gerhard Kirsch, Renate Mentel, Birgit Fürll, Marina Freudenberg, Gerd Schmitz, Felix Stelter, Christine Schütt, Lipopolysaccharide-binding protein is required to combat a murine Gram-negative bacterial infection Nature. ,vol. 389, pp. 742- 745 ,(1997) , 10.1038/39622
K Onozuka, M Nakano, Y Terada, H Shinomiya, Y Nakano, Protective effect of recombinant tumor necrosis factor-α in murine salmonellosis. Journal of Immunology. ,vol. 144, pp. 1935- 1941 ,(1990)
R L Berkow, J W Larrick, R W Dodson, D Wang, T H Howard, Enhancement of neutrophil superoxide production by preincubation with recombinant human tumor necrosis factor. Journal of Immunology. ,vol. 139, pp. 3783- 3791 ,(1987)
D Gosselin, J DeSanctis, M Boulé, E Skamene, C Matouk, D Radzioch, Role of tumor necrosis factor alpha in innate resistance to mouse pulmonary infection with Pseudomonas aeruginosa. Infection and Immunity. ,vol. 63, pp. 3272- 3278 ,(1995) , 10.1128/IAI.63.9.3272-3278.1995
E A Havell, Evidence that tumor necrosis factor has an important role in antibacterial resistance. Journal of Immunology. ,vol. 143, pp. 2894- 2899 ,(1989)
John C. Mathison, Philippe Sansonetti, Christine Wennerås, Patrick Ave, Michel Huerre, Josette Arondel, Richard J. Ulevitch, Blockade of CD14 IncreasesShigella-Mediated Invasion and Tissue Destruction The Journal of Immunology. ,vol. 164, pp. 3214- 3221 ,(2000) , 10.4049/JIMMUNOL.164.6.3214